Catalogue preview · final packaging and presentation may vary if stockedFive choices across your ballotUse votes only for compounds you would consider ordering
One vote per compoundEach candidate can be selected once on this browser
Flexible interest signalRemove or reassign a vote whenever you like
HEXARELIN
Hexarelin, also called examorelin, is a synthetic six-amino-acid ghrelin-receptor agonist. It is studied in pituitary growth-hormone release and in exploratory cardiovascular models.
Loading your saved choices…
HEXARELIN is currently being evaluated through customer voting and is not available to order. Final product specifications and batch documentation will be published only if it joins the catalogue.
This page records catalogue interest only. If HEXARELIN is selected for supply, Puffin will publish the confirmed format, batch documentation, and laboratory preparation information on the product listing.
Storage and handling requirements depend on the final supplied format. Confirmed instructions will be provided with the batch details if this candidate is added to the catalogue.
Understanding Hexarelin
Explore the science, research focus, and key information behind this compound.
What is Hexarelin?+
Hexarelin is commonly compared with other secretagogues when receptor activity and broader signalling profiles matter.
What Researchers Study+
Researchers examine Ghrelin-receptor activity, Pituitary release models, and Cardiovascular signalling.
How Hexarelin Works+
Hexarelin activates GHSR1a, producing a strong GH-release signal and, in some settings, smaller ACTH, cortisol, or prolactin responses. In plain language, it uses the ghrelin receptor like other GHRPs but has its own potency and endocrine profile.
Research at a Glance+
Potent acute GH release has been documented. Small human physiology studies support GHSR-mediated GH secretion. They do not establish durable changes in muscle, body composition, recovery, or health outcomes. Other pituitary-adrenal signals can move too. Compared with ipamorelin, hexarelin may produce more ACTH, cortisol, or prolactin activity in some settings. Those hormones belong in a careful comparison. Cardiovascular animal signals remain exploratory. Preclinical heart and vascular findings can guide mechanism studies but do not establish a cardiac treatment or clinical protection.
If this candidate is added to the catalogue, it would be offered for controlled laboratory research only. It is not for human consumption and is not represented as a medicine, treatment, supplement, or substitute for an approved product.